Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3123 | 2060 | 47.1 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
1300 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE | 8578 |
3123 | 1 | PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | 2060 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PPAR DELTA | authKW | 721780 | 4% | 55% | 88 |
2 | PPAR BETA DELTA | authKW | 434964 | 2% | 68% | 43 |
3 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | authKW | 395799 | 8% | 16% | 172 |
4 | PPAR | authKW | 373689 | 8% | 15% | 163 |
5 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA | authKW | 364799 | 2% | 62% | 40 |
6 | GW501516 | authKW | 184684 | 1% | 69% | 18 |
7 | GW0742 | authKW | 164172 | 1% | 92% | 12 |
8 | MOL TOXICOL CARCINOGENESIS | address | 162591 | 3% | 19% | 57 |
9 | PPAR AGONIST | authKW | 161814 | 2% | 35% | 31 |
10 | ATHEROSCLEROSE | address | 158951 | 3% | 21% | 52 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 10996 | 22% | 0% | 453 |
2 | Endocrinology & Metabolism | 1871 | 13% | 0% | 260 |
3 | Biochemistry & Molecular Biology | 1755 | 27% | 0% | 560 |
4 | Pharmacology & Pharmacy | 1223 | 16% | 0% | 337 |
5 | Chemistry, Organic | 952 | 11% | 0% | 230 |
6 | Cell Biology | 616 | 11% | 0% | 221 |
7 | Medicine, Research & Experimental | 546 | 7% | 0% | 148 |
8 | Peripheral Vascular Diseases | 368 | 5% | 0% | 96 |
9 | Biophysics | 232 | 5% | 0% | 102 |
10 | Dermatology | 122 | 2% | 0% | 49 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL TOXICOL CARCINOGENESIS | 162591 | 3% | 19% | 57 |
2 | ATHEROSCLEROSE | 158951 | 3% | 21% | 52 |
3 | FRONTIERS GENET | 121363 | 1% | 30% | 27 |
4 | U545 | 74912 | 2% | 16% | 31 |
5 | INTEGRAT GENOM | 52403 | 3% | 6% | 60 |
6 | NUCL RECEPTOR DISCOVERY | 50943 | 1% | 25% | 14 |
7 | TAKARA BIO ENDOWED | 49915 | 0% | 42% | 8 |
8 | MOL BIOL TUMOR IMT | 46365 | 1% | 24% | 13 |
9 | METAB DIS EXCELLENCE DRUG DISCOVERY | 46313 | 0% | 63% | 5 |
10 | METAB DIS CHEM | 46162 | 0% | 35% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PPAR RESEARCH | 144480 | 3% | 14% | 69 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 13817 | 7% | 1% | 154 |
3 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 3142 | 1% | 1% | 24 |
4 | JOURNAL OF MEDICINAL CHEMISTRY | 2821 | 3% | 0% | 65 |
5 | CHEMMEDCHEM | 2302 | 1% | 1% | 19 |
6 | MOLECULAR ENDOCRINOLOGY | 2169 | 1% | 1% | 29 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY | 1945 | 2% | 0% | 42 |
8 | CURRENT OPINION IN INVESTIGATIONAL DRUGS | 1223 | 0% | 1% | 7 |
9 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1200 | 1% | 0% | 28 |
10 | CURRENT OPINION IN LIPIDOLOGY | 1100 | 0% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PPAR DELTA | 721780 | 4% | 55% | 88 | Search PPAR+DELTA | Search PPAR+DELTA |
2 | PPAR BETA DELTA | 434964 | 2% | 68% | 43 | Search PPAR+BETA+DELTA | Search PPAR+BETA+DELTA |
3 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | 395799 | 8% | 16% | 172 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR |
4 | PPAR | 373689 | 8% | 15% | 163 | Search PPAR | Search PPAR |
5 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA | 364799 | 2% | 62% | 40 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+DELTA | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+DELTA |
6 | GW501516 | 184684 | 1% | 69% | 18 | Search GW501516 | Search GW501516 |
7 | GW0742 | 164172 | 1% | 92% | 12 | Search GW0742 | Search GW0742 |
8 | PPAR AGONIST | 161814 | 2% | 35% | 31 | Search PPAR+AGONIST | Search PPAR+AGONIST |
9 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BETA DELTA | 151758 | 1% | 64% | 16 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+BETA+DELTA | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+BETA+DELTA |
10 | PPARS | 140587 | 2% | 22% | 44 | Search PPARS | Search PPARS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PIRAT, C , FARCE, A , LEBEGUE, N , RENAULT, N , FURMAN, C , MILLET, R , YOUS, S , SPECA, S , BERTHELOT, P , DESREUMAUX, P , ET AL (2012) TARGETING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARS): DEVELOPMENT OF MODULATORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 9. P. 4027 -4061 | 134 | 79% | 55 |
2 | NEELS, JG , GRIMALDI, PA , (2014) PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BETA.PHYSIOLOGICAL REVIEWS. VOL. 94. ISSUE 3. P. 795 -858 | 221 | 34% | 33 |
3 | GREWAL, AS , BENIWAL, M , PANDITA, D , SEKHON, BS , LATHER, V , (2016) RECENT UPDATES ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS FOR THE TREATMENT OF METABOLIC SYNDROME.MEDICINAL CHEMISTRY. VOL. 12. ISSUE 1. P. 3 -21 | 101 | 86% | 0 |
4 | LOIODICE, F , POCHETTI, G , (2011) STRUCTURAL INSIGHT INTO THE CRUCIAL ROLE OF LIGAND CHIRALITY IN THE ACTIVATION OF PPARS BY CRYSTALLOGRAPHIC METHODS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 11. ISSUE 7. P. 819-839 | 99 | 87% | 5 |
5 | EHRENBORG, E , SKOGSBERG, J , (2013) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AND CARDIOVASCULAR DISEASE.ATHEROSCLEROSIS. VOL. 231. ISSUE 1. P. 95-106 | 83 | 85% | 15 |
6 | MICHALIK, L , AUWERX, J , BERGER, JP , CHATTERJEE, VK , GLASS, CK , GONZALEZ, FJ , GRIMALDI, PA , KADOWAKI, T , LAZAR, MA , O'RAHILLY, S , ET AL (2006) INTERNATIONAL UNION OF PHARMACOLOGY. LXI. PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 4. P. 726-741 | 124 | 44% | 418 |
7 | PETERS, JM , FOREMAN, JE , GONZALEZ, FJ , (2011) DISSECTING THE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-BETA/DELTA (PPAR BETA/DELTA) IN COLON, BREAST, AND LUNG CARCINOGENESIS.CANCER AND METASTASIS REVIEWS. VOL. 30. ISSUE 3-4. P. 619 -640 | 104 | 71% | 16 |
8 | ZHANG, J , LIU, X , XIE, XB , CHENG, XC , WANG, RL , (2016) MULTITARGETED BIOACTIVE LIGANDS FOR PPARS DISCOVERED IN THE LAST DECADE.CHEMICAL BIOLOGY & DRUG DESIGN. VOL. 88. ISSUE 5. P. 635 -663 | 86 | 77% | 0 |
9 | WAGNER, KD , WAGNER, N , (2010) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BETA/DELTA (PPAR BETA/DELTA) ACTS AS REGULATOR OF METABOLISM LINKED TO MULTIPLE CELLULAR FUNCTIONS.PHARMACOLOGY & THERAPEUTICS. VOL. 125. ISSUE 3. P. 423-435 | 115 | 56% | 59 |
10 | BORSOTTO, M , VEYSSIERE, J , MAATI, HMO , DEVADER, C , MAZELLA, J , HEURTEAUX, C , (2015) TARGETING TWO-PORE DOMAIN K+ CHANNELS TREK-1 AND TASK-3 FOR THE TREATMENT OF DEPRESSION: A NEW THERAPEUTIC CONCEPT.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 172. ISSUE 3. P. 771 -784 | 75 | 72% | 11 |
Classes with closest relation at Level 1 |